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Objectives. The purpose of this experimental study was to compare the susceptibility of gelatin-sealed Dacron and PTFE
prostheses to infection by MRSA.
Design. Prospective, randomized, controlled animal study.
Materials and Methods. Graft infections were established in the subcutaneous tissues of 60 female Spraque-Dawley rats
by the implantation of gelatin-sealed Dacron or PTFE prostheses followed by topical inoculation with methicillin-resistant
Staphylococcus aureus. The study groups were as follows: (1A) uncontaminated gelatin-sealed Dacron group, (1B) un-
treated contaminated gelatin-sealed Dacron group, (1C) contaminated gelatin-sealed Dacron group with intraperitoneal
teicoplanin treatment, (2A) uncontaminated PTFE group, (2B) untreated contaminated PTFE group, and (2C) contami-
nated PTFE group with intraperitoneal teicoplanin treatment. The grafts were removed after 7 days and evaluated for
infection by counting the number of adherent bacteria on the graft material after rinsing and sonication. The perigraft
tissue was harvested for histopathological study. To investigate the existence of any infection, blood samples were collected
by cardiopuncture for a culture analysis.
Results. No significant difference in bacteria counts was observed between gelatin-sealed Dacron and PTFE grafts. In
groups 1A and 2A, there was no infection detected. The bacterial counts for MRSA were 7.4 105 in group 1B and
8.6 105 in group 2B. There was also no infection in groups 1C and 2C. While the difference between group 1B and
2B was not significant (p> .05), bacterial counts in group 1B or 2B were significantly higher than those in other groups.
Blood cultures were only positive in four rats in group 1B and in two rats in group 2B. The severities of the inflammation
of the perigraft tissues was low in groups 1A and 2A, high in groups 1C and 2C, and between the range from low to mod-
erate in groups 1B and 2B.
Conclusion. The susceptibility of gelatin-sealed Dacron to bacterial infection was not higher than that of PTFE.
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The use of vascular prostheses has dramatically
changed the surgical outcomes in vascular patients.
However, vascular prostheses are associated with
a number of complications, including bacterial infec-
tion. Vascular graft infections are relatively uncom-
mon and have an incidence of 0.5e6%.1,2 Despite
their infrequency, vascular graft infections are associ-
ated with significant morbidity and mortality and ex-
ist as a dreaded complication of vascular surgery.1e3
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in vascular surgery are polyethylene terephthalate
(Dacron) and polytetrafluoroethylene (PTFE). They
have been made from polymers and used in clinical
settings for about 40 years. There is general agreement
that Dacron grafts are associated with a greater risk of
thrombosis and infection. This belief is based on an
earlier in vitro experimental study which suggests
that PTFE grafts are less susceptible to infection than
Dacron grafts.4 However, the preference of PTFE
over Dacron is not due to clinical but rather experi-
mental evidence. Most clinical studies have found
no significant difference in these grafts.5e8 Moreover,
it has been reported that new generation Dacron pros-
theses seem to be superior to PTFE prostheses.9
In addition, no in vivo experimental studies com-
paring the use of Dacron with that of PTFE were
found by means of a review of the literature, and itrved.
426 A. Yasim et al.was not determined whether Dacron is more prone
to develop infection when compared to PTFE in an
in vivo experiments. The present study was planned
to test and compare the susceptibilities of Dacron
and PTFE grafts to MRSA infections using a standard-
ized well characterized experimental rat model.10
Material and Methods
Organism
The strain of Methicillin-resistant Staphylococcus
aureus (MRSA) used in this study was isolated from
a clinical specimen submitted for routine bacteriolog-
ical investigation to the Department of Microbiology,
Faculty of Medicine, Kahramanmaras Sutcu Imam
University, Turkey. Commercially available Staphylo-
coccus aureus ATCC 25923 was used as the control
strain of methicillin susceptibility test. The organism
was incubated overnight on sheep blood agar. The
numbers of the bacteria were determined by turbi-
dimetry and confirmed by the culture results.
Drugs
Teicoplanin (Targocid) used in this study was
obtained from Aventis Pharma (Istanbul, Turkey). Tei-
coplanin was dissolved in sterile distilled water at
a concentration of 4 mg/ml. Solutions were made
fresh on the day of the experiments.
Susceptibility testing
The antimicrobial susceptibility of the strains were
determined by using the microbroth dilution method,
according to the procedures outlined by the National
Committee for Clinical Laboratory Standards. The min-
imum inhibition concentration was taken to be the low-
est antibiotic concentration at which observable growth
was inhibited.Experimentswereperformed in triplicate.
Rat model
The study was approved by the Ethics Committee of
Faculty of Medicine, Kahramanmaras Sutcu Imam
University, Turkey. Sixty adult female Sprague-
Dawley rats (weight range, 200 to 250 g) were studied.
All rats had free access to standard rat chow and tap
water. The rats were divided into two main groups.
Group 1 received gelatin-sealed Dacron graft and
Group 2 received PTFE graft. Both group included
a control group with no graft contamination and no
antibiotic prophylaxis (group 1A and 2A), oneEur J Vasc Endovasc Surg Vol 32, October 2006contaminated group that did not receive antibiotic
prophylaxis (group 1B and 2B), and one contaminated
group that received perioperative 10 mg/kg intraperi-
toneal teicoplanin treatment (group 1C and 2C). Teico-
planin administration began from the initiation of
surgery and continued twice a day in the following
72 h. All operations were performed under sterile con-
ditions. Each group included 10 animals. The rats were
anesthetizedwith intraperitoneal ketamine (10 mg/kg)
and xylazine (3 mg/kg). The hair on the backs was
shaved, and the skin was cleaned with 10% povidone-
iodine solution. One subcutaneous pocket was made
on the right side of themedian line by a 1.5 cm incision.
Aseptically, 1 cm2 sterile gelatin-sealed Dacron grafts
(Gelseal; Sulzer Vascutek Ltd, UK) or PTFE grafts
(Gore-Tex; W.L. Gore & Associates Inc, USA) were
implanted into the pockets. The pockets were closed
by 5/0 polypropylene sutures (Dogsan, Turkey), and
a sterile saline solution (1 mL) containing the MRSA
strain at a concentration of 2 107 CFU/mL was inoc-
ulated onto the graft surface using a tuberculin syringe
to create a subcutaneous fluid-filled pocket (group 1B,
2B, 1C and 2C). The animals were returned to individ-
ual cages and thoroughly examined daily. They were
euthanized by an overdose of anesthesia after seven
days following implantation. Under sterile conditions,
all grafts were explanted for bacteriological study. The
perigraft tissue was harvested for histological study.
Additionally, blood samples were collected via cardio-
puncture for culture analysis in order to assess the
existence of any infection.
Assessment of the infection
The explanted grafts were placed in sterile tubes and
washed in sterile saline solution. Thereafter, they were
placed in tubes containing 10 mL of phosphate-
buffered saline solution and sonicated for 5 min to
remove the adherent bacteria from the grafts. Quanti-
fication of viable bacteria was performed by preparing
serial 10-fold dilutions (0.1 ml) of the bacterial suspen-
sions in 10 mM buffer to minimize the carryover effect
and by culturing each dilution on blood agar plates.
All plates were incubated at 37 C for 48 h and evalu-
ated for the presence of the MRSA strain. The organ-
isms were quantified by counting the number of CFU
per plate. The threshold of detection for this method
was approximately 5 101 CFU/cm2 per graft tissue.
Analysis of blood culture
The blood samples were drawn by cardiopuncture
after cleaning the skin with 10% povidone-iodine.
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4 ml into BACT/Alert PlusþAerobic/F blood culture
bottles and were placed in the blood culture instru-
ment (BACT/ALERT PF Pediatric BIOMERIEUX
INC., Durham.). All bottles were incubated for a
period of 7 days. Whenever there was a sign of micro-
bial growth, the detection time was documented. The
bottles that had a positive signal were smeared and
stained with Gram stain. Subcultures on blood agar,
chocolate agar and MacConkey agar plates were also
used. Subcultures were incubated at 35 C for dura-
tion of 48 h. When growth was detected, identification
of S. aureus was performed by Mini API and conven-
tional methods. The time of detection was measured
in hours, beginning with the placement of the bottles
in the instrument and ending with the positive signal
of the instrument.
Histopathological study
The perigraft tissuewas taken. The tissueswere fixed in
a formalin solution for amaximumof 24e48 h. Samples
were washed with water and were soaked in a graded
series of ethanol (60, 70, 80, 90, and 100%). Then they
were held in a solution of xylene for 90 min and were
embedded in paraffin at 60 C. Cross sections (5 mm
thick) were cut. Hematoxylin and eosin (H&E) staining
was used for the histological examination.
All perigraft tissues were examined for signs of
inflammation and infection and classified semi-
quantitatively as follows: grade 0; no neutrophils,
grade I; a low number of neutrophils, grade II; a mod-
erate number of neutrophils, and grade III; a high
number of neutrophils as proposed by Hernandez-
Richter et al.11
Statistical analysis
Quantitative culture results for all groups are pre-
sented as mean standard deviation, and the statisti-
cal comparisons between groups were made using
Kruskal-Wallis analysis of variance followed by
post-hoc ManneWhitney U test. Statistical signifi-
cance was defined as a P value of <.05. Statistical
analyses were performed using SPSS 9.0 for Windows
(SPSS Inc., Chicago, IL).
Results
The assessment of graft infection
Depending on the microbiological study, none of
the animals included in groups 1A and 2A(uncontaminated groups) showed any signs of graft in-
fection. On the contrary, there were severe signs of in-
fection on microbiological examination in all rats in
groups 1B and 2B (untreated contaminated groups)
with quantitative culture data showing 7.4 105
2.0 105 cfu/cm2 grafts and 8.6 105 2.1 105
cfu/cm2 grafts, respectively. Between groups 1B and
2B, there was no significant difference in the results
from quantitative bacterial graft cultures (P> .05). In
addition, groups 1C and 2C, contaminated and treated
with intraperitoneal teicoplanin, showed no evidence
of staphylococcal infection on microbiologic examina-
tion with quantitative cultures below the limit of detec-
tion. Data concerning the quantitative results and
statistical comparisons of the groups are summarized
in Table 1.
Analysis of blood culture
The animals in groups 1A and 2A had sterile postop-
erative blood cultures. In group 1B, bacterial cultures
of the blood were positive in 4 animals and negative
in 6 animals. In group 2B, blood cultures were posi-
tive in 2 animals and negative in 8 animals. In both
groups 1C and 2C, blood cultures were negative in
all rats (Table 2).
Histopathological study (Table 3)
The severity of the inflammation of the perigraft tis-
sue in uncontaminated groups (groups 1A and 2A)
Table 1. Quantitative microbiological results of in vivo
experiments












2A uncontaminated PTFE group 0b,e
2B untreated contaminated
PTFE group
8.6 105 2.1105 a,c,d,f




Each group consisted of 10 animals and statistical significance was
evaluated by using Kruskal-Wallis analysis of variance followed by
post-hoc Mann-Whitney test.
a statistically significant versus group 1A.
b statistically significant versus group 1B.
c statistically significant versus group 1C.
d statistically significant versus group 2A.
e statistically significant versus group 2B.
f statistically significant versus group 2C.Eur J Vasc Endovasc Surg Vol 32, October 2006
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tween the two groups (P> .05). On the contrary, in
contaminated untreated groups (groups 1B and 2B)
the severity was high. While the difference between
groups 1B and 2B was not significant (P> .05), the dif-
ferences between groups 1A and 1B and between 2A
and 2B were significant (P< .01). In groups 1C and
2C, the severity of the inflammation of perigraft tissue
was between the range from low to moderate. There
was not any significant difference between groups
1C and 2C (P> .05). Similarly, no difference between
groups 1A and 1C and between groups 2A and 2C
was observed (P> .05), in spite of the higher degree
of the inflammation seen in groups 1C and 2C. More-
over, despite the higher degree of the inflammation in
groups 1B and 2B when compared to that of groups
1C and 2C, these differences were also not significant
(P> .05).
Discussion
In the present study, the susceptibility of distinct vas-
cular grafts, gelatin-sealed Dacron and PTFE, to
MRSA infection was investigated. There was no dif-
ference in bacterial counts between two vascular
grafts after inoculation of MRSA strain, and teicopla-
nin administration prevented the occurrence of vascu-
lar graft infections. In groups with MRSA infection,
the severities of perigraft inflammations in both grafts
were greater than those in other experimental groups.
Despite the use of aseptic vascular surgical tech-
niques and prophylactic antibiotics, vascular graft
infection remains as an uncommon, but devastating
complication in vascular surgery. The mainstays of
prophylaxis are asepsis and perioperative administra-
tion of systemic antibiotics.10 Recently, antibiotic-
bonded grafts have been also used as an adjunctive
therapy for preventing vascular graft infection.1,2,10
Table 2. Bacteriologic evaluation of blood cultures
Groups Positive blood culture Groups Positive blood culture
1A 0/10 2A 0/10
1B 4/10 2B 2/10
1C 0/10 2C 0/10Eur J Vasc Endovasc Surg Vol 32, October 2006Unfortunately, vascular prostheses that are resistant
to infection are yet unavailable.
The most frequently used prosthetic materials in
vascular surgery are Dacron and PTFE grafts. PTFE
has gained wide acceptance as a conduit in peripheral
vascular surgery because of the opinion that it has
lower complication rates than Dacron. However, there
has been no clear evidence for its susceptibility to
infection. Several clinical studies reported that there
was no difference between Dacron and PTFE grafts
in their ability to resist against infection.5e7 While
Zeltsman et al.12 reported that vascular graft infection
was more frequently seen in patients receiving PTFE
than Dacron, the reverse was reported in other stud-
ies.13,14 However, none of these studies had sufficient
power to detect a significant difference.
It has been generally accepted that Dacron has
a tendency to infection. The basis of this consideration
is Schmitt’s study,4 in where PTFE was found to have
lower quantitative bacterial adhesion compared to
Dacron fabrics. They suggested that this difference
in bacterial affinity is the result of the hydrophilic po-
rosity of the Dacron graft. This observation is opposite
to our data. The reason of this difference between the
above mentioned study and ours may be that Schmitt
used an in vitro model and we used an in vivo model.
In addition, they used old generation woven Dacron
and velour knitted Dacron material and we used
new generation gelatin-sealed Dacron. Gelatin sealing
lowers the incidence of early bacterial infection. This
effect is probably due to a decrease in the porosity
of polyester with gelatin-sealing.15 The PTFE material
has a microporous structure and is relatively non-
porous compared to the old generation materials.
A study by Camiade et al.15 compared the resis-
tance of allograft and synthetic prostheses and
showed that bacterial infection of Dacron prostheses
was generally higher than PTFE prostheses and gela-
tin-sealed Dacron prostheses. But they suggested that
differential resistances of infection in these prostheses
were due to distinct strains of bacteria. Methodologi-
cal differences of studies may also play an important
role in this difference (in vivo versus in vitro).
There are some limitations in our study. First, the
animal model used in the present study is not directlyTable 3. Inflammation intensity results of in vivo experiments
Group 1A Group 1B Group 1C Group 2A Group 2B Group 2C
Grade 0 þþþ þ þþ
Grade 1 þþþþþ þþ þþþþ þþþþþþ þþþþ
Grade 2 þþ þþþ þþ þþ þþþþ þþþ
Grade 3 þþþþþ þþþ þþþþþþ þþþ
þ indicates the number of the perigraft tissues involved in each grade category.
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Eur J Vasc Endovasc Surg Vol 32, October 2006comparable with graft implantation into a blood ves-
sel, and caution is needed in relating these results to
patients. Further investigations using big animal
models are required. Nevertheless, we feel that our
in vivo results are more relevant than previous in vitro
studies. In this study, we examined only the early
graft infection on the postoperative 7 days, but not
lateeappearing vascular prosthetic vascular graft
infection. Finally we examined only infection with
MRSA and not other mixed bacterial populations
(Figs. 1 and 2).
PTFE and Dacron vascular graft possess many of
the properties of the ideal vascular prostheses, but
are highly hydrophobic surfaces that limit endothelial
Fig. 1. Light micrograph of hematoxylin and eosin (H&E,
x20) stained sections from perigraft tissue. Note the abun-
dant neutrophilic infiltrate in the fibrous tissue.
Fig. 2. Light micrograph of hematoxylin and eosin (H&E,
x20) stained sections from perigraft tissue. Note the de-
creased neutrophilic infiltrate in the fibrous tissue.surface adhesion.8 Modifications of these prostheses
surfaces that stimulate endothelialization could resist
bacterial infection. Vascular prostheses are potential
sources of future infections. Dacron may be more
likely to develop at least a partial ‘pseudointima’, ren-
dering it less susceptible to late bacteraemic seeding.16
Early Dacron grafts were not ideal substitutes for vas-
cular surgery. Subsequently, efforts to increase the
quality of Dacron grafts led to marked improvements
in those prostheses.17 The operative experience and
short-term results with newer Dacron grafts may be
profitable.
In conclusion, in our model there is no differences
in the incidence of infection of Dacron or PTFE graft.
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